ImmunoPrecise Antibodies (IPA) Scheduled to Post Earnings on Thursday

ImmunoPrecise Antibodies (NASDAQ:IPA) will post its quarterly earnings results before the market opens on Thursday, July 25th. Analysts expect ImmunoPrecise Antibodies to post earnings of ($0.10) per share for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

ImmunoPrecise Antibodies Stock Down 2.4 %

IPA stock opened at $0.83 on Wednesday. ImmunoPrecise Antibodies has a 1-year low of $0.80 and a 1-year high of $2.73. The business’s 50 day moving average is $1.02 and its 200-day moving average is $1.39. The company has a current ratio of 1.66, a quick ratio of 1.38 and a debt-to-equity ratio of 0.25.

ImmunoPrecise Antibodies Company Profile

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes.